InvestorsHub Logo
Followers 20
Posts 643
Boards Moderated 0
Alias Born 06/12/2015

Re: None

Thursday, 01/05/2017 9:35:19 PM

Thursday, January 05, 2017 9:35:19 PM

Post# of 4220
You need to step back and look at the big picture. It's way way bigger than huge, bigger than gigantic, it's unprecedented in scope.

It most likely will be Amyris technology that leads to the cure of cancer, and hundreds of other diseases. Any Pharma/biotech not working with Amyris will be left in the dust on new drug discovery. It's a must have. Collaborations will continue to mount and accelerate going forward with AMRS getting a cut of the action on future discoveries and drug production. All of this while cutting cost of production by a factor of 10 to 100. Just to get an idea of what you're looking at, take a look at 5% of drug sales of the 3 pharma/bios we already have, J&J, Biogen, Novartis... IT's over 100B x 5% =5B Of coarse cost will be less, so prices should go down. Just an example of how a small piece of the pie could generate big profits ahead.

AMRS will even be able to get some current drug sales by producing the product at a substantial savings to current cost.

Don't get excited yet, there's more....continued later.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRSQ News